Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:ASPI News 5 December 2025

ASP Isotopes (NASDAQ: ASPI) Stock: CEO Comeback, HALEU Progress and 2026 Outlook

ASP Isotopes (NASDAQ: ASPI) Stock: CEO Comeback, HALEU Progress and 2026 Outlook

Updated December 5, 2025 – informational only, not investment advice. ASP Isotopes Stock Snapshot as of December 5, 2025 ASP Isotopes Inc. (NASDAQ: ASPI) continues to trade like a classic high‑risk, high‑story growth name. According to StockAnalysis, revenue over the last twelve months is only about $8–9 million, which implies a price‑to‑sales ratio above 50x and an EV/Sales ratio above 80x at recent prices – valuations that assume significant future growth. StockAnalysis+1 Analyst coverage is still thin: two analysts currently rate ASPI a “Strong Buy” with an average 12‑month price target of $12, implying potential upside of more than 80%
5 December 2025
·

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Go toTop